Last Week in GER Research: Meituan, Nio, Haidilao, Shandong Gold, China Renais., X Financial and PDD
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we dig into the economics of Mobike as it relates...
372 Views
Last Week in GER Research: Meituan, China Tower, Haidilao, Qutoutiao, Hua Med., Chunlai, and Cootek
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we assess Meituan's latest results ahead of its...
328 Views
111 Inc. (1药网) IPO Review - Key Operating Metrics of B2C Segment Has Been Declining
111 Inc (YI US) is looking to raise up to about US$150m in its upcoming IPO. Proceeds from IPO will be mainly used for research and development and...
347 Views
Last Week in GER Research: Meituan-Dianping, Nio, Gangfeng Lithium, Pinduoduo and 111 Inc
Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we highlight a more palatable...
337 Views
111 Inc IPO Valuation: Pricing Does Not Adequately Reflect the Risks
111 Inc (YI US) announced its IPO price range of $14-16 per ADS. At the mid-point of the IPO price range, 111 will raise net proceeds of...
557 Views